Esclerose múltipla: aspectos clínicos, diagnóstico e tratamento
Revista ft · 2026-06-14 · 30 (159) · 01-06
DOI: 10.69849/b296za31 ↗At a glance
Journal article in Revista ft, published online on 2026-06-14. Written by Raul Felipe Garcia Silva and 1 co-authors. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Multiple sclerosis (MS) is an inflammatory, autoimmune, and demyelinating disease of the central nervous system that predominantly affects young adults. It is characterized by recurrent episodes of inflammation and destruction of the myelin sheath, leading to progressive neurological deficits and varying degrees of functional disability. The aim of this study is to review the main aspects related to the pathophysiology, clinical manifestations, diagnosis, and treatment of multiple sclerosis. This is a narrative review of scientific literature conducted using national and international databases. The results demonstrate that early diagnosis and timely initiation of disease-modifying therapies significantly contribute to reducing clinical progression and improving patients' quality of life. Although there is no definitive cure, immunomodulatory and immunosuppressive therapies have a relevant impact on controlling relapses and disease progression. It is concluded that a multidisciplinary and individualized approach remains essential in the management of multiple sclerosis.
Cite
APA
Silva, R. F. G., & Botelho, L. F. V. (2026). Esclerose múltipla: aspectos clínicos, diagnóstico e tratamento. Revista ft, 30(159), 01-06. https://doi.org/10.69849/b296za31
Vancouver
Silva RFG, Botelho LFV. Esclerose múltipla: aspectos clínicos, diagnóstico e tratamento. Revista ft. 2026;30(159):01-06. doi:10.69849/b296za31
BibTeX
@article{Silva2026,
author = {Silva, Raul Felipe Garcia and Botelho, Luiz Filipe Vieira},
title = {Esclerose múltipla: aspectos clínicos, diagnóstico e tratamento},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {159},
pages = {01--06},
doi = {10.69849/b296za31}
}
EUVIMED